<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03098212</url>
  </required_header>
  <id_info>
    <org_study_id>3487</org_study_id>
    <nct_id>NCT03098212</nct_id>
  </id_info>
  <brief_title>Aromatherapy for Reducing Labor Pain</brief_title>
  <official_title>Efficacy of Aromatherapy for Reducing Pain During Labor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ChaingMai University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ChaingMai University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pregnant women who eligible with inclusion criteria are random to two groups. Aromatherapy
      group will receive the aromatherapy during labor along with standard pain control.

      Non-aromatherapy group will receive standard pain control during labor
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 2015</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>early active phase pain using Visual Analog Scale</measure>
    <time_frame>The day of labor</time_frame>
    <description>Visual analog scale used to assess pain during cervical dilate 5-7 cm.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>latent phase pain using Visual Analog Scale</measure>
    <time_frame>The day of labor</time_frame>
    <description>Visual analog scale used to assess pain during cervical dilate 3-4 cm.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>late active phase pain using Visual Analog Scale</measure>
    <time_frame>The day of labor</time_frame>
    <description>Visual analog scale used to assess pain during cervical dilate 8-10 cm.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>analgesic drug</measure>
    <time_frame>The day of labor</time_frame>
    <description>doses of analgesic drug request by pregnant women</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">94</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Aromatherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Receive essential oil diffuse by Aroma diffuser during labor. Pain score and dose of analgesics drug are recorded</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-aromatherapy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This group receive pain control by standard of care without essential oil (aromatherapy)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Aromatherapy</intervention_name>
    <description>On the day of admission for labor. Pregnant women select type of essential oil. Aroma diffuser is used during labor. Pain score was record during latent, early active and late active phase.</description>
    <arm_group_label>Aromatherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Singleton pregnancy

          -  Nulliparous

          -  37 complete weeks of gestation

          -  Cephalic presentation

          -  No emergency obstetric complication

          -  In labor

        Exclusion Criteria:

          -  Medical or obstetric complication preclude vaginal delivery

          -  Essential oil allergy

          -  Side effect of aromatherapy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 8, 2017</study_first_submitted>
  <study_first_submitted_qc>March 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 31, 2017</study_first_posted>
  <last_update_submitted>March 27, 2017</last_update_submitted>
  <last_update_submitted_qc>March 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>ChaingMai University</investigator_affiliation>
    <investigator_full_name>Kuntharee Traisrisilp</investigator_full_name>
    <investigator_title>Principle investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

